Last reviewed · How we verify
Effect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study)
The purpose of this study is to find if Rituximab can improve severe ocular lesions of Behcet's Disease.
Details
| Lead sponsor | Tehran University of Medical Sciences |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 20 |
| Start date | 2006-04 |
| Completion | 2008-01 |
Conditions
- Behcet's Syndrome
Interventions
- Rituximab
- Cytotoxic Combination
Primary outcomes
- Visual acuity — 6 months
Countries
Iran